Core Viewpoint - In 2025, Jianlong Micro-Nano's overall operations showed steady improvement, with enhanced profitability and operational quality, driven by market expansion and product optimization [1][2]. Financial Performance - Jianlong Micro-Nano achieved operating revenue of 841 million yuan, a year-on-year increase of 7.97% [1]. - The company reported a net profit attributable to shareholders of 98.52 million yuan, reflecting a year-on-year growth of 31.79% [1]. - The adjusted net profit reached 94.65 million yuan, up 55.75% year-on-year [1]. - The gross profit margin was 31.92%, an increase of 3.57 percentage points compared to the same period last year [1]. Business Strategy - The company focused on optimizing its product structure, with over a hundred products emphasizing high-margin categories, leading to significant sales growth in high-margin products across various applications [1][2]. - Jianlong Micro-Nano's business strategy includes consolidating its traditional molecular sieve adsorbent business while actively developing new products and fields, particularly in new materials and technical services [2]. Market Position and Growth - The company maintained a competitive advantage in gas separation, medical oxygen production, and adsorption drying, with sales revenue growth and effective cost control contributing to a steady recovery in gross profit margin [2]. - In 2025, Jianlong Micro-Nano achieved foreign sales revenue of 217 million yuan, a year-on-year increase of 9%, accounting for 25.8% of total revenue [2]. Industry Outlook - The growth of Jianlong Micro-Nano in 2025 aligns with the overall trend in the molecular sieve industry, characterized by stable demand, improved structure, and enhanced efficiency [3]. - The company aims to continue its dual-driven development strategy, focusing on four key areas: petrochemicals, energy chemicals, renewable resources, and renewable energy, while transitioning from new material manufacturing to comprehensive technical services [3].
优化产品结构与降本并行 建龙微纳2025年归母净利润同比增长31.79%